GLOBUS MEDICAL is trading at 78.00 as of the 21st of December 2024, a 2.5% down since the beginning of the trading day. The stock's lowest day price was 78.0. GLOBUS MEDICAL has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 21st of November 2024 and ending today, the 21st of December 2024. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. GLOBUS MEDICAL's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding GLOBUS MEDICAL or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
GLOBUS MEDICAL A (GM0N) is traded on Berlin Exchange in Germany and employs 12 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GLOBUS MEDICAL's market, we take the total number of its shares issued and multiply it by GLOBUS MEDICAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
GLOBUS MEDICAL generates positive cash flow from operations, but has no cash available
Check GLOBUS MEDICAL Probability Of Bankruptcy
GLOBUS MEDICAL A Risk Profiles
Although GLOBUS MEDICAL's alpha and beta are two of the key measurements used to evaluate GLOBUS MEDICAL's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in GLOBUS MEDICAL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Funds Screener Now
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Elected by the shareholders, the GLOBUS MEDICAL's board of directors comprises two types of representatives: GLOBUS MEDICAL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GLOBUS. The board's role is to monitor GLOBUS MEDICAL's management team and ensure that shareholders' interests are well served. GLOBUS MEDICAL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GLOBUS MEDICAL's outside directors are responsible for providing unbiased perspectives on the board's policies.
GLOBUS MEDICAL financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL security.